Beijing Kawin Technology Share-Holding Co Ltd
688687
Company Profile
Business description
Beijing Kawin Technology Share-Holding Co Ltd is a biotechnology company. It offers healthcare solutions for liver disease. The company's products include Pirfenidone Tablets, Peginterferon Alfacon-2 Injection, and Compound glycyrrhizin capsules.
Contact
No. 6, Rongjing East Street
Building 3, Beijing Economic and Technological Development Zone
Beijing100176
CHNT: +86 1067892271
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
600
Stocks News & Analysis
stocks
Eli Lilly receives FDA approval to add another oral GLP-1 to market
Wide moat Eli Lilly receives FDA approval for obesity pill.
stocks
Our top ASX picks in every sector
These companies are our favourite choices for investors wanting to boost Aussie equity exposure.
stocks
Which of the 3 giant AI IPOs should you buy?
OpenAI, Anthropic, and Databricks are expected to go public this year at massive valuations.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,774.90 | 124.80 | -1.40% |
| CAC 40 | 7,909.79 | 71.48 | -0.90% |
| DAX 40 | 22,953.83 | 345.06 | -1.48% |
| Dow JONES (US) | 46,565.74 | 224.23 | 0.48% |
| FTSE 100 | 10,351.88 | 12.91 | -0.12% |
| HKSE | 25,116.53 | 177.50 | -0.70% |
| NASDAQ | 21,840.95 | 250.32 | 1.16% |
| Nikkei 225 | 52,463.27 | 1,276.41 | -2.38% |
| NZX 50 Index | 12,902.15 | 76.28 | 0.59% |
| S&P 500 | 6,575.32 | 46.80 | 0.72% |
| S&P/ASX 200 | 8,579.50 | 105.50 | -1.21% |
| SSE Composite Index | 3,919.29 | 29.27 | -0.74% |